Myo-inositol and an Antioxidant Mix for the Treatment of Vietnamese Infertile Men
Can Myo-inositol in Combination With N-Acetyl-Cysteine Plus an Antioxidant Mix be Useful for the Management of Men Affected by Idiopathic Infertility and Semen Hyperviscosity?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hanoi, Vietnam
- Recruiting
- Hung Nguyen
-
Contact:
- Hung three Nguyen, Medical doctor
- Phone Number: +84 989 200 940
- Email: hung2779@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI < 29
- One year of unsuccessful sexual intercourses without achieving pregnancy for male factor (idiopathic infertility)
- Normospermia, isolated asthenozoospermia and/or oligoasthenozoospermia
- Semen hyper-viscosity defined as severe, moderate and mild
Exclusion Criteria:
- The absence of spermatozoa production
- Positive presence of leucocyte and inflammation factor in the seminal fluid
- Positive urea test for the presence of bacteria, protozoa and/or fungi infection
- Diagnosis of cryptorchidism
- Diagnosis of Varicocele of grade 2 or higher
- Diagnosis of Diabetes and other pathology causing oxidative stress
- Concentration alterations of the following hormones: LH, FSH, Testosterone, Prolactin, 17b-estradiol
- Abuse of alcohol and controlled substance
- Smoking cigarettes (>10 cigarettes/day)
- BMI > 30
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Andrositol Plus
all the patients will be treated for three months with a dietary supplement containing Myo-inositol, NAC, Folic acid, selenium, vitamin E, L-Arginine and L-Carnitine
|
Myo-inositol
N-Acetyl-Cysteine
Folic Acid
Selenium
L-arginine
L-carnitine
Vitamin E
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in sperm motility
Time Frame: spermatozoa motility will be analyzed after 3 months of treatment
|
spermatozoa motility will be evaluated through microscopical evalutation
|
spermatozoa motility will be analyzed after 3 months of treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in sperm morphology
Time Frame: spermatozoa morphology will be analyzed at the enrollment and after 3 months of treatmentanalyzed
|
spermatozoa morphology will be evaluated through microscopical evalutation
|
spermatozoa morphology will be analyzed at the enrollment and after 3 months of treatmentanalyzed
|
|
change in sperm vitality
Time Frame: spermatozoa vitality will be analyzed after 3 months of treatment
|
spermatozoa vitality will be evaluated through vitality test with methylene blue
|
spermatozoa vitality will be analyzed after 3 months of treatment
|
|
change in sperm count
Time Frame: spermatozoa count will be 3 months of treatment
|
spermatozoa count will be evaluated through microscopical evalutation
|
spermatozoa count will be 3 months of treatment
|
|
change in seminal fluid viscosity
Time Frame: semen Hyper-viscosity will be analyzed after 3 months of treatment
|
Viscosity will be determined after ejaculation by gently aspirating semen into a 5 ml pipette and then producing semen drops.
|
semen Hyper-viscosity will be analyzed after 3 months of treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MAVIM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.